Page last updated: 2024-08-26

bosentan anhydrous and Mitral Valve Insufficiency

bosentan anhydrous has been researched along with Mitral Valve Insufficiency in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
He, F; Ren, R; Xiao, X	1

Other Studies

1 other study(ies) available for bosentan anhydrous and Mitral Valve Insufficiency

Article	Year
Bosentan treatment for pulmonary arterial hypertension due to complete atrioventricular septal defect in an infant with Down's syndrome. International journal of cardiology, 2014, Dec-20, Volume: 177, Issue:3 Topics: Antihypertensive Agents; Bosentan; Down Syndrome; Heart Septal Defects; Humans; Hypertension, Pulmonary; Infant; Male; Mitral Valve Insufficiency; Sulfonamides; Treatment Outcome; Ultrasonography	2014

Article

Year

Bosentan treatment for pulmonary arterial hypertension due to complete atrioventricular septal defect in an infant with Down's syndrome.

International journal of cardiology, 2014, Dec-20, Volume: 177, Issue:3

Topics: Antihypertensive Agents; Bosentan; Down Syndrome; Heart Septal Defects; Humans; Hypertension, Pulmonary; Infant; Male; Mitral Valve Insufficiency; Sulfonamides; Treatment Outcome; Ultrasonography

2014